Weed, Inc. (BUDZ): Operating Income
-$1.33M
Year ended 2025-12-31
-$1.05M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.33M | n/m | 2026-04-08, From 2025-01-01 |
| 2024-12-31 | -$530.0K | n/m | 2026-04-08, From 2024-01-01 |
| 2023-12-31 | -$770.6K | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$1.51M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$2.80M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$4.08M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$27.42M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$28.41M | n/c | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$2.38M | n/a | 2019-04-16, From 2017-01-01 |
| No annual figure between 2011-12-31 and 2017-12-31. | |||
| 2011-12-31 | $2.09M | +322.3% | 2012-04-16, From 2011-01-01 |
| 2010-12-31 | $494.1K | n/a | 2012-04-16, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Weed, Inc. (BUDZ) | 2025-12-31 | -$1.33M | n/m |
| NRC Health (NRC) | 2025-12-31 | $22.59M | -35.8% |
| Incyte Corp (INCY) | 2025-12-31 | $1.51B | n/m |
| Icon PLC (ICLR) | 2025-12-31 | $442.85M | -57.1% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $25.16M | -88.9% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$51.90M | n/m |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | -$421.4K | n/m |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $2.18B | -0.9% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | -$8.98M | n/m |
Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗